Can a phone app tame fatty liver? 2,000-Person trial launches
NCT ID NCT07233486
First seen Nov 18, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study tests a digital software tool that helps doctors guide patients with MAFLD (a common fatty liver disease) through lifestyle changes and remote monitoring. About 2,000 adults aged 18–65 with overweight or obesity will use the app to track weight and blood sugar. The goal is to see if the software can safely help reduce weight and improve blood sugar control, since no approved drug exists for this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAFLD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hangzhou Normal University Hospital
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.